Connect with us on:       

April 18, 2014
Issue 11

In This Newsletter

Connect with Specialty Pharmacy Community:  Advertise or post jobs to reach 9,000+ Specialty Pharmacy professionals, contact us. Act quickly, as     advertising in the Specialty Pharmacy Newsletter is selling out.

Make sure you are noticed: HE Business Directory, get listed today.

In this issue:

  • News: Some MDs Support Sovaldi Pricing (Really!); The Tamiflu “Myth”: Roche & Cochrane Square Off; Pipeline for SPRx; SPRx Jobs Across the Globe.
  • Spotlight Feature 2:  Real-World Evidence in the fastest growth area of Pharma, Specialty Pharma: inVentiv Health clinical – Discover a New Paradigm in Late Stage Research by inVentiv Health clinical
  • Newsletter Sponsor: McKesson Specialty Health. Develop an HEOR Strategy that Addresses Stakeholder Requirements. Perfect for Specialty Pharma drugs and more. Learn more about our services today. Pharmaceutical and Biotech Solutions.
  • Link of the Week: HE Business Directory – List Your Consulting Company, HEOR Department, SPRx Group, Graduate Dept and more.
  • Conference of the Week: If you attend one conference this Summer, go here: DIA 2014 50th Annual Meeting, June 15-19, San Diego, CA. Celebrate the Past – Invent the Future. Register by May 9 to Make the Advance Attendee list!


Looking for a way to reach Stakeholders in Pharma and Specialty Pharma? Options for every budget. Contact us.

Industry News

What Treatments Are Looming in the Specialty Pipeline? Advances in the treatment of Hep C and Cancer ar prolific – and high-priced. See what’s in the pipeline for SPRx. (Source: Specialty Pharmacy Times, 4/9/2014)

Why Are Some Doctors Standing By Gilead's Hep C Sovaldi Pricing? At the recent European Association for the Study of the Liver conference in London, doctors told governments and insurers to look at the big picture; Sovaldi will save payers  from the cost of long-term complications of the disease, besides, oncology drugs are already priced in this range-and excepted…that makes it ok, right? (Source: Arlene Weintraub, FiercePharma, 4/11/14).

Webinar: Introduction to the Hepatitis C Impact Monitor (HCIM). Zitter Health Insights offer this webinar taking place Wednesday, April 30 from 1:00-2:00pm EDT. It will cover 1) What is Hepatitis C Impact Monitor (HCIM)?, 2)Topics we cover and how might that change over time, 3) Awareness and assessment, future category management and administration burden and prescribing. RSVP needed to attend. (Source: Zitter Health Insights, 4/16/2014)

Are Oncologists Ready To Embrace Real-World Data? FirstWord Pharma polled 192 US and EU5 oncologists to gain some insight into the physician perceptive towards real-world data. (Source: FirstWord Pharma, 4/14/14).

Specialty Pharmacy Considerations for Hemophilia Inhibitors. Hemophilia is a bleeding disorder that is usually passed on through genetics. Donna Haffler, RN, BSN, Walgreens Specialty Pharmacy, and Kirstin Schmidt, RN, national clinical director, bleeding disorders program, Walgreens Specialty Pharmacy, led a session at the NASP 2014 Specialty Pharmacy EXPO on hemophilia inhibitors and their role in specialty pharmacy. (Source: First Report Managed Care, 4/8/2014)

Managed Care Focus on MS, Hepatitis C, and PAH. During a session at the NASP 2014 Specialty Pharmacy EXPO, Jayne Hornung, RPh, vice president, pharmacy and medical data, Managed Markets Insight & Technology, discussed the effects of multiple sclerosis (MS), hepatitis C, and pulmonary arterial hypertension (PAH) in managed care. Dr. Hornung noted that there are commonalities between these 3 disease states: (1) they have a number of medications in each class; (2) they can require prior authorizations for the medications; (3) they have an injectable formulation; and (4) they have seen recent oral agent approvals. (Source: First Report Managed Care, 4/7/2014)

Under-Insured Patients Transforming Specialty Pharmacy Care – How? In the opening keynote address, Sandy Robinson, BA, MPA, vice president, Avalere, said, "There will be patients who are underinsured,” noting that we can expect to see a shift from uninsured to underinsured patients, meaning patients are more fiscally responsible for their care now. (Source: First Report Managed Care, 4/8/2014)

Specialty Drug Approvals in 2013. The year 2013 marked the approval of many new specialty medications, with drug debuts and new indications in areas including oncology, hepatitis C, HIV, multiple sclerosis, and inflammatory disease. This article provides a selection of specialty pharmacy– related FDA approvals and expanded indications for 2013. (Source: Pharmacy Times, 3/13/2014)

Read the Latest Drug Trend Report: Year in Review. Express Scripts recently published the 2013 Drug Trend Report  which notes that overall drug spend increased by 5.4% in 2013, following several years of declining rate increases. Utilization of traditional prescription medications grew only slightly (0.5%) from 2012 to 2013, but the use of specialty medications increased 2.5%. Overall trend was driven by a 2.4% increase in spend for traditional (nonspecialty) medications and a 14.1% increase in spend for specialty medications, one of the lowest specialty drug trends ever recorded. However, specialty medications contributed an ever-increasing share (27.7%) of total spend that is expected to continue to grow. (Source: Express Scripts, 2014)

How Insurers Can Cut Specialty Drug Costs. Specialty medication costs continue to rise challenging payers. According to a new Milliman report commissioned by CVS Caremark, health insurers can move prescription benefits from medical to pharmacy coverage to off-set these costs. Such a transition would save up 19.7 percent on specialty drugs, while allowing payers to implement more effective management tools, such as formulary design, utilization management, and preferred or exclusive networks. (Source: FierceHealthPayer, 4/11/2014)

Catch Up, If You Missed It:  AMCP Specialty Pharmacy Conference. Were you there? Feedback from this year's event was very positive. If you missed it or want to relive the experience you can read the blog from AMCP's Annual Meeting & Expo. (Source: AMCP, April 2014)

... Read All News

Spotlight 1 of the Week

Spotlight 2 of the Week

Survey of the Week

Interested in running a poll or survey of HealthEconomics.Com readers?

Test an idea or field your specialty pharmacy questions here. This spot is available. Contact us.

Conference Of The Week

Link of the Week


HE Business Directory

1,000 Visitors/Month. Why Not Get Listed?

List Your Consulting Company, HEOR Department, SPRx Group, Graduate Dept and more.


The Tamiflu Myth:  Roche and Cochrane Collaboration Square Off

Is the lack of transparency in clinical trials making it easy for Big Pharma toMisrepresent products? Taking Tamiflu's story of an "industry accepted" practice of selective dissemination of clinical trial results, inconsistencies, and cover ups, this article describes a pivotal moment in the history of medicine, calling for a change in legislation as well as a cultural shift. Are we ready to push for this change? Read more here. (Source: Ben Goldacre, The Guardian, 4/9/14).

Job of the Week


HealthCore Late Phase Resarch Manager

HealthCore - Andover, MA


Reserve "Job of the Week". Contact us.

Job Title Location
Research Scientist, Health Economics Modeling & Simulation
Bethesda, Maryland
Research Scientist, Health Economics Modeling & Simulation
Lexington, Massachusetts
HealthCore Late Phase Resarch Manager-81539
Andover, Massachusetts
Manager, Pricing and Market Access, CHicago, USA
Chicago, Illinois
Manager, Health Economics and Outcomes Research, Chicago, USA
Chicago, Illinois
View All Jobs


Dates Conference Title Location
Apr 22 - Apr 23, 2014 A Model Of Patient, Payer and Product Developer Collaboration To Support Innovating For Value Washington, DC USA
Apr 23 - Apr 23, 2014 Cognitive Interviewing for Evaluating Measurement Equivalence of Electronically Migrated PRO Instruments Branbury, Oxfordshire UK
Apr 23 - Apr 24, 2014 Europe Clinical Trials Outsourcing and Partnering Conference Frankfurt Germany
Apr 23 - Apr 24, 2014 Europe Data Management in Clinical Trials Conference 2014 Frankfurt Germany
Apr 23 - Apr 25, 2014 MASS East Philadelphia, PA
View All Conferences